Inhaler/Nasal
RELVAR ELLIPTA INHALATION POWDER, PRE-DISPENSED 200MCG/25MCG
Summary
RELVAR ELLIPTA INHALATION POWDER, PRE-DISPENSED 200MCG/25MCG — Inhaler/Nasal containing fluticasone furoate, vilanterol (as trifenatate). Hong Kong Registration No. HK-62694. Certificate Holder: GLAXOSMITHKLINE LIMITED. Date of Registration: 12 Mar, 2014.
Product NameRELVAR ELLIPTA INHALATION POWDER, PRE-DISPENSED 200MCG/25MCG
Registration No.HK-62694
Certificate HolderGLAXOSMITHKLINE LIMITED
Holder AddressFLAT/RM 04-10, 10/F, TOWER 6, THE GATEWAY, 9 CANTON ROAD, TSIM SHA TSUI, KOWLOON
Ingredientsfluticasone furoate, vilanterol (as trifenatate)
Dosage FormInhaler/Nasal
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration12 Mar, 2014
ATC codesR01AD12, R03BA09
ATC Classification
ATC level 1
R Respiratory System
All ATC groupsR01, R03
This product contains more than one active ingredient. The ATC groups above describe the ingredients, not a single category for the product as a whole.
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。